Effects of tesamorelin on hepatic transcriptomic signatures in HIV-associated NAFLD

Nonalcoholic fatty liver disease (NAFLD) is a common comorbidity among people living with HIV that has a more aggressive course than NAFLD among the general population. In a recent randomized placebo-controlled trial, we demonstrated that the growth hormone–releasing hormone analog tesamorelin reduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Fourman, Lindsay T., Billingsley, James M., Agyapong, George, Ho Sui, Shannan J., Feldpausch, Meghan N., Purdy, Julia, Zheng, Isabel, Pan, Chelsea S., Corey, Kathleen E., Torriani, Martin, Kleiner, David E., Hadigan, Colleen M., Stanley, Takara L., Chung, Raymond T., Grinspoon, Steven K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455119/
https://www.ncbi.nlm.nih.gov/pubmed/32701508
http://dx.doi.org/10.1172/jci.insight.140134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455119/
https://www.ncbi.nlm.nih.gov/pubmed/32701508
http://dx.doi.org/10.1172/jci.insight.140134

Ejemplares similares